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Derivation and Validation of a Modiﬁed Short Form of the Stroke
Impact Scale
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Kennedy R. Lees, MD; Terence J. Quinn, MD, FRCP; on behalf of the VISTA Collaboration
Background-—The Stroke Impact Scale (SIS) is a stroke-speciﬁc, quality of life measure recommended for research and clinical
practice. Completion rates are suboptimal and could relate to test burden. We derived and validated a short form SIS (SF-SIS).
Methods and Results-—We examined data from the Virtual International Stroke Trial Archive, generating derivation and validation
populations. We derived an SF-SIS by selecting 1 item per domain of SIS, choosing items most highly correlated with total domain
score. Our validation described agreement of SF-SIS with original SIS and the SIS-16 and correlation with Barthel Index, modiﬁed
Rankin Scale, National Institutes of Health Stroke Scale, and Euro-QoL 5 dimensions visual analog scales. We assessed
discriminative validity (associations between SF-SIS and factors known to inﬂuence outcome [age, physiological parameters, and
comorbidity]). We assessed face validity and acceptability by sharing the SF-SIS with a focus group of stroke survivors and
multidisciplinary stroke healthcare staff. From 5549 acute study patients (mean age 68.5 [SD 13] years, mean SIS 64 [SD 32]) and
332 rehabilitation patients (mean age 65.7 [SD 11] years, mean SIS 61 [SD 11]), we derived an 8-item SF-SIS that demonstrated
good agreement with original SIS and good correlation with our chosen functional and quality of life measures (all q>0.70,
P<0.0001). Signiﬁcant associations were seen with our chosen predictors of stroke outcome in the acute group (P<0.0001). The
focus group agreed with the choice of items for SF-SIS across 7 of 8 domains.
Conclusions-—Using multiple, complementary methods, we have derived an SF-SIS and demonstrated content, convergent,
and discriminant validity. This shortened SIS should allow collection of robust quality of life data with less associated test burden.
( J Am Heart Assoc. 2016;5:e003108 doi: 10.1161/JAHA.115.003108)
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M any outcome assessments are available to measurestroke recovery, often with compromise between test
burden and richness of data captured.1 Traditionally clinicians
and researchers have favored impairment or activity assess-
ments.2 From the stroke survivor perspective, these scales
may be overly reductionist.3 Patient-reported outcome mea-
sures (PROMs) are self-report questionnaires designed to
capture the impact of ill health on a broad range of areas that
inﬂuence quality of life (QOL). PROMs have been found to
provide unique insights into the clinical status of stroke
survivors.4 There is no single PROM that has become
universally accepted in stroke. In a recent structured review
of PROMs for use in stroke, the Stroke Impact Scale (SIS)5
was selected as having a well-documented and thorough
development history, together with good psychometric prop-
erties.6
This SIS is a stroke-speciﬁc, health-related QOL measure
(HR-QOL). SIS assesses 60 items across 8 domains. The
multidomain testing inherent in SIS results in a tool that can
take considerable time to complete. This may limit the scale’s
use in practice, particularly in time-pressured environments or
for stroke survivors with persisting physical and cognitive
impairments. In a multidisciplinary, expert consensus state-
ment, time required for SIS assessment was noted as a major
limitation for stroke survivors.6 A proxy SIS form has been
described; however, proxy responses may not correlate with
patient QOL perceptions.7 The ideal would be a brief
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assessment that maintains the psychometrics strengths of
SIS.
Internal consistency of SIS is high, suggesting a degree of
redundancy in scale items.8 This ﬁnding would support
removing some items to create a shorter form. A modiﬁed
version of SIS, limited to physical domains, has been
described (SIS-16),9 but there is no accepted short form of
the complete SIS. Using data from 73 stroke survivors, it was
shown that an 8-item short form is possible with favorable
properties.10 These pilot data are encouraging but require
robust, independent assessment and validation. In particular,
it is important that validation work is carried out using
populations independent of the derivation cohort and that
there is opportunity for key stakeholders, both medical and
lay persons, to comment on the short form scale.
We used the patient-level data held in the Virtual
International Stroke Trials Archive (VISTA) to derive and
validate a short form of the SIS (SF-SIS).
Methods
We used the VISTA resource for our derivation and validation.
VISTA is a not-for-proﬁt repository for stroke trial data,
containing study-quality data on thousands of participants.11
All studies contained within VISTA and associated work have
been approved by an institutional review committee and
included participants, or their proxies, provided informed
consent. The VISTA data sets have been used to investigate
various novel hypotheses including analyses of stroke
assessment scale properties.12
Data Set
VISTA data sets predominantly used version 3.0 of the SIS
scale with domains of strength (4 items), hand function (5
items), mobility (9 items), activities of daily living (ADLs) (10
items), memory (7 items), communication (7 items), emotion
(9 items), and societal participation (8 items). Some acute
data sets used the modiﬁed SF-16; this version of the scale
had fewer items for domains of strength (0 items), hand
function (1 item), mobility (8 items), and ADLs (7 items).
Domains are scored on a metric of 0 to 100, with higher
scores indicating better self-reported health. Some of the
available SIS data sets also contained a visual analog scale
(VAS) describing global QOL. Where certain domain items of
SF-SIS were unavailable, as original data had used SIS-16, we
substituted with the best-ﬁt available item (hand function:
“carry heavy objects”) or did not include that item in analysis
(strength domain).
We selected all patient-level, anonymized data that
contained SIS along with any other outcome measures of
interest. Our chosen comparator outcomes were other
PROMs (EuroQOL EQ-5D, EQ-5D-VAS, and SIS-VAS) or
functional outcome measures (Barthel Index [BI], modiﬁed
Rankin Scale [mRS], and National Institutes of Health Stroke
Scale [NIHSS]). A priori, we decided to treat data from acute
stroke trials and from rehabilitation studies separately. We
divided the data set using a randomized 60:40 split to create
cohorts for independent derivation and validation analyses.
Descriptive Analyses
We described clinical and demographic features of the main
data set. We described the distribution of scores on SIS
globally and for each domain. We assessed internal consis-
tency, using Cronbach’s a, for the complete SIS and for each
domain. Where data were collected at >1 time-point, we used
the time-point that gave the largest data set. For acute
studies, “baseline” assessments were generally within ﬁrst
24 hours; for rehabilitation studies, “baseline” assessments
were predominantly at 4 weeks post ictus.
Derivation Analyses
We described correlation, by using Spearman’s q, for each
domain item relative to the domain total score and selected
the single item per domain with the greatest correlation. All
analyses were performed in the acute and rehabilitation
data sets and compared. We compared the resulting, 8-item
VISTA-derived short form (ie, SF-SIS) with the short form
from our previous pilot work (herein referred to as SF-SIS
[pilot]).
Validation Analyses
We assessed convergent validity by describing the agree-
ment of SF-SIS with the original SIS or SIS-16 and by
describing correlation of SF-SIS with other functional (BI,
mRS, and NIHSS) and QOL (EQ-5D, EQ-VAS, and SIS-VAS)
outcomes where available. EQ-5D data were transformed
into a single index using the Europe-VAS data set.13 As a
check of discriminant validity, we performed linear univari-
ate regressions to assess association of SF-SIS with, where
data were available, clinical and demographic features
known to inﬂuence outcome (age, baseline stroke severity,
physiologic variables, cardiac disease, prior stroke, and use
of thrombolytic therapy) and described odds of a point
change in SF-SIS associated with unit change in other
outcomes. All analyses were performed in the acute and
rehabilitation data sets and compared. All analyses were
performed with the use of SAS version 9.3 (SAS Institute)
software.
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Focus Group
We conducted a focus group to assess the opinions of key
stakeholders on the original and short forms of SIS and other
QOL scales. We invited multidisciplinary staff involved in
stroke care, focusing on those who regularly use PROMS in
clinical practice. We also invited stroke survivors and their
carers, asking for volunteers through a Stroke Research
Network managed database. We presented the full SIS, SIS-
16, SF-SIS, as well as EQ-5D and the Short Form-36 (SF-12).
Participants were asked to compare and comment on the
various scales in terms of content, perceived ease of
completion, and relevance to stroke. Participants were then
asked to rate items from each domain of the full SIS and to
comment on preferred items. The group was led by one of the
authors (M.P.), and all participants were encouraged to
contribute. Responses were transcribed in real time and
reviewed by a researcher independent of the main study
group who described and collated common themes in
participant responses (PM, see Acknowledgments).
The ﬁnal decision on content of the SF-SIS was based on
results from the pilot data10; the derivation and validation
analyses presented here and the opinions of the focus group.
We selected those items that were favored in ≥2 of these 3
data sources (Figure).
Results
The VISTA database had SIS data on 5549 acute trial
participants and 332 rehabilitation study participants. The
rehabilitation data set had data at various time-points
(baseline, 1 month, 3 month, 1 year). We used the baseline
data set for analyses because this was the largest data set.
In the past week, how would you rate the strength of your leg that was most affected 
by your stroke?
In the past week, how difficult was it for you to think quickly?
In the past week, how often did you feel that you have nothing to look forward to?
In the past week, how difficult was it to understand what was being said to you in a 
conversation?
In the past 2 weeks, how difficult was it to do light household tasks/chores (eg, dust, 
make a bed, take out the rubbish, do the dishes)?
In the past 2 weeks, how difficult was it to walk without losing balance?
In the past 2 weeks, how difficult was it to use your hand that was most affected by 
your stroke, to pick up a coin?
During the past 4 weeks, how much of the time have you been limited in your social 
activities?
Score each statement from 1 to 5:
1 = Could not do at all; 
2 = very difficult;
3 = somewhat difficult; 
4 = a little difficult; 
5 = not difficult at all.
Figure. Short-form Stroke Impact Scale.
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The included patients consisted of 2445 (44%) female patients
in the acute data set (mean age 68.5 [SD 13] years) and 107
(32%) female patients in the rehabilitation data set (65.7 [SD
11.0] years; Tables 1 and 2).
There was a spread of SIS scores across both data sets: for
acute data, mean SIS 64.5 (SD 32.4), and for rehabilitation
data, mean SIS 61.2 (SD 11.0). Internal consistency for
complete SIS was high, with a=0.98 (acute) and a=0.93
(rehabilitation). Across both data sets, for individual domains
the internal consistency was generally high (>0.85) for all
domains other than “emotion” with a=0.60 (acute) and
strength a=0.77 and emotion a=0.63 (rehabilitation).
In both data sets, we described individual items that
correlated best with the corresponding domain. The best-
performing rehabilitation items agreed with the acute data for
all domains that had a full data set and agreed with the
original SF-SIS (pilot) for 5 of 8 items (Table 3).
We validated our SF-SIS in our acute data set. Agreement
of SF-SIS with SIS-16 was excellent, a=0.92. SF-SIS showed
strong correlations with all our chosen outcome measures:
mRS (0.83), BI (0.82), NIHSS (0.77), EQ-5D (0.82), and
EQ-VAS (0.72); correlations were equivalent to those seen for
full SIS (0.87, 0.89, 0.77, 0.88, and 0.73, respectively)
(Table 4). On linear univariate analyses, age, stroke severity
(NIHSS), baseline blood pressure (systolic), baseline glucose,
previous stroke, cardiac disease (atrial ﬁbrillation), and use of
thrombolysis were all associated (P<0.0001) with SF-SIS
(Table 5).
Using the rehabilitation data set, agreement of SF-SIS with
SIS was excellent, a=0.96. SF-SIS showed signiﬁcant
(P<0.0001) correlation with BI (q=0.65), EQ-5D (q=0.69),
EQ-VAS (q=0.45), and SIS-VAS (q=0.57). Correlations were
roughly equivalent to those seen for full SIS (0.72, 0.69, 0.46,
and 0.58, respectively) (Table 4). SF-SIS was signiﬁcantly
(P<0.0001) associated with certain predictors of stroke
severity, age, and baseline stroke severity (BI) but not with
previous stroke or cardiac disease (heart failure) (Table 6).
Focus Group
Thirteen people attended the focus group: 3 research nurses,
2o ward nurses (acute and rehabilitation settings), 1 occupa-
tional therapist, 1 physiotherapist, 1e stroke physician, 1
clinical psychologist, 3 stroke survivors, and 1 caregiver. On
analysis of free-form responses, themes were that wording of
certain SIS items was confusing in places; that the original SIS
was too long, albeit provided more detail than the short
scales; and that certain important aspects of recovery were
not adequately captured. On direct questioning, the group
preferred the SF-SIS to the other scales presented but had
concerns that in shortening the scale, some important details
would be lost (Data S1). Preferred domain items from SIS
were those included in SF-SIS for 7 of the 8 domains
(Table 3). For the 2 domains (communication and activities of
daily living) where SF-SIS did not agree with the original SF-
SIS (pilot), the focus group preferred the SF-SIS wording.
Table 1. Clinical and Demographic Features of the VISTA
Data Set—Acute Stroke Trial Data Set
Age, y 68.5 (13)
Baseline NIHSS, median (IQR) 12 (9)
Systolic blood pressure, mm Hg 156.5 (27)
Glucose at baseline, mmol/L 7.6 (3.06)
Female 2445 (44%)
Use of thrombolysis 1915 (35%)
Intracerebral hemorrhage 603 (11%)
Diabetes mellitus 1247 (23%)
Hypertension 4157 (75%)
Atrial fibrillation 1325 (24%)
Previous stroke 1046 (19%)
Transient ischemic attack 439 (8%)
Ischemic heart disease 1710 (31%)
Myocardial infarction 661 (12%)
Congestive heart failure 485 (9%)
Data are given as n (%) for nominal data and as mean (SD) for other data unless
otherwise stated. NIHSS indicates National Institutes of Health Stroke Scale; VISTA,
Virtual International Stroke Trials Archive.
Table 2. Clinical and Demographic Features of the VISTA
Data Set—Rehabilitation Study Data Set
Variable All Stroke Types
Age, y, mean (SD) 65.73 (10)
Baseline BI, median (IQR) 15 (7)
Female 107 (32%)
LACS 59 (18%)
PACS 118 (36%)
TACS 143 (43%)
Atrial fibrillation 45 (13%)
Hypertension 243 (73%)
Diabetes mellitus 44 (13%)
Ischemic heart disease 67 (20%)
Heart failure 8 (2%)
Previous stroke 57 (17%)
Intracerebral hemorrhage 46 (14%)
Data are given as n (%) for nominal data and as mean (SD) for other data unless
otherwise stated. BI indicates Barthel Index; LACS, lacunar stroke; NIHSS, National
Institutes of Health Stroke Scale; PACS, partial anterior circulation stroke; TACS, total
anterior circulation stoke; VISTA, Virtual International Stroke Trials Archive.
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Table 3. Correlation (Spearman’s q) of Individual Items With
Total Domain Score Across Various Stroke Impact Scale Data
Sets
Domain/Item Within Domain Acute Rehabilitation
SF
Pilot
Focus
Group
1. Strength dimension
a) Strength of arm NA 0.708
b) Grip of hand NA 0.704
c) Strength of leg* NA 0.809 Y Y
d) Strength of foot NA 0.791
2. Memory dimension
a) Remember things that
people just told you
0.880 0.794
b) Remember things that
happened the day before
0.906 0.790
c) Remember to do things 0.906 0.767
d) Remember the day of
the week
0.880 0.685
e) Concentrate 0.907 0.851 N
f) Think quickly* 0.916 0.866 Y
g) Solve everyday problems 0.901 0.819
3. Emotion dimension
a) Feel sad 0.681 0.673
b) Feel that there is nobody
you are close to
0.640 0.520
c) Feel that you are a
burden to others
0.704 0.674
d) Feel that you have nothing
to look forward to*
0.747 0.722 Y Y
e) Blame yourself for
mistakes that you made
0.608 0.603
f) Enjoy things as much as
ever
0.539 0.438
g) Feel quite nervous 0.573 0.535
h) Feel that life is worth
living
0.609 0.657
i) Smile and laugh at least
once a day
0.613 0.581
4. Communication dimension
a) Say the name of someone 0.864 0.770
b) Understand what was
being said
0.804 0.627 N
c) Reply to questions 0.914 0.816
d) Correctly name objects 0.894 0.736
e) Participate in a
conversation*
0.921 0.854 Y
f) Have a conversation on
phone
0.921 0.881
Continued
Table 3. Continued
Domain/Item Within Domain Acute Rehabilitation
SF
Pilot
Focus
Group
g) Call another person on
the phone
0.856 0.798
5. ADL dimension
a) Cut your food with a
knife and fork?
NA 0.475
b) Dress top half of your
body?
0.877 0.705
c) Bathe yourself? 0.896 0.755
d) Clip your toenails? NA 0.549
e) Get to the toilet on time? 0.905 0.699 N
f) Control your bladder? 0.741 0.545
g) Control your bowels? 0.702 0.398
h) Do light household
tasks?*
NA 0.793 N Y
i) Go shopping? 0.871 0.705
j) Do heavy household
chores?
0.839 0.676
6. Mobility dimension
a) Sit without losing your
balance?
0.690 0.485
b) Stand without losing
your balance*
0.892 0.823
c) Walk without losing your
balance
0.922 0.851 Y
d) Move from bed to chair? 0.895 0.817
e) Walk down one street? 0.913 0.862
f) Walk fast? 0.888 0.662 N
g) Climb one flight of stairs? 0.910 0.846
h) Climb several flights of
stairs
0.741
i) Get in and out of a car? 0.915 0.783
7. Hand function dimension NA
a) Carry heavy objects? 0.815 0.708
b) Turn a door knob NA 0.836
c) Open a can or a jar? NA 0.781
d) Tie a shoelace? NA 0.658
e) Pick up a coin?* NA 0.841 Y Y
8. Social participation dimension
a) Your work 0.834 0.735
b) Your social activities* 0.900 0.766 Y Y
c) Quiet recreation 0.839 0.704
d) Active recreation 0.856 0.722
e) Your role as a family
member/friend
0.828 0.541
Continued
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Discussion
We have suggested a shortened form of the SIS and validated
the measure by using a multimodal approach. The resulting
SF-SIS is robust and broadly acceptable to stroke survivors
and clinical/research staff. We believe our SF-SIS could have
use as an outcome measure in stroke research, as quality
metric in audit (using a short QOL measure to benchmark and
compare services) and as a tool for assessing patient recovery
in clinical practice.
Capturing stroke speciﬁc QOL data by using PROMs can be
challenging. The SIS has been suggested as the optimal
PROM for this purpose as it has been shown to be reliable,
valid, and sensitive to change.14 However, there are examples
of clinical studies where SIS was used as an end-point
measure and, as a result of perceived burden, questionnaire
return rates were so poor as to invalidate the study.15 In the
pilot that informed earlier work on short forms of SIS, >40% of
the questionnaire returns had missing items.10 The problem of
lengthy completion time limiting the use of an otherwise good
stroke outcome measure is not unique to SIS. Even relatively
short assessments such as BI have shown poor completion
because of perceived test burden.16 Because there is
evidence of redundancy in the full SIS, a short form approach
is attractive. Where short forms of lengthy questionnaires are
available, they can often replace the original as the test of
choice; for example, the short form (16 items) of the
Informant Questionnaire for Cognitive Decline in the Elderly
is now the preferred version,17 and the recently described
short form of the Parkinson’s Disease Questionnaire18 is now
commonly used.19 Short forms may have particular use
in situations where time available for testing is limited or
when used as a component of an outcomes battery in a large
clinical trial. A measure of success of a short form is that it
takes less time to complete than the original instrument.
Reviews of SIS describe time to complete as 20 minutes,20
although administration may be longer still in stroke survivors
with more complex impairments. Within the development
group, we tested SF-SIS and found time to complete of
<1 minute. Further work, testing our SF-SIS in an unselected,
“real-world” population of stroke survivors, is now needed.
There is no perfect assessment scale for stroke survivors.
The choice of instrument will depend on the properties of that
scale and purpose of testing. A primary limitation of SIS
concerns feasibility and acceptability. Other commonly used
scales in stroke are limited by imperfect reliability (mRS), ﬂoor
and ceiling effects (BI), and poor validity for certain stroke
syndromes (NIHSS).21–23 The context of testing is also
important. We tested SIS by using data from “acute” and
“rehabilitation” settings and found reasonable validity for
both. Our short form may have use early in stroke recovery at
a time when detailed testing may not be feasible. Future work
should examine all psychometric properties of SF-SIS across
various settings where PROMs may be used.
The work presented is an extension of our original
description of an SF-SIS using UK primary care data. The
SF-SIS derived from the VISTA data agreed with the original
short form for most domains, suggesting reasonable validity
of these items. Where there was disagreement between SF-
SIS items selected for inclusion here and previous work, we
chose to use the items preferred by our focus group. Thus, the
SF-SIS described here may be preferable as it has been tested
Table 3. Continued
Domain/Item Within Domain Acute Rehabilitation
SF
Pilot
Focus
Group
f) Your participation in
spiritual activities
0.810 0.692
g) Your ability to control
your life
0.891 0.783
h) Your ability to help others 0.894 0.782
Data are correlation of individual items scores with total domain score. In the acute data
set, certain items were not available (NA). Data are presented for our acute trial and
rehabilitation study data sets. We compare best-performing items (highlighted with *)
with those reported in our initial short-form pilot work (SF pilot) and our focus group,
labeling “Y” where there was agreement with our derived SF-SIS and “N” where preferred
items differ. Final choice of questions for the SF-SIS was based on those items those
that were favored in ≥2 of the 3 data sets: pilot work, main analysis, and focus group.
Table 4. Correlation (Spearman’s q) of SIS and Short-Form
SIS With Other Quality of Life and Functional Outcome
Measures
SIS SF-SIS
Acute trial data
SIS 1.00
SF-SIS 0.94 1.00
mRS 0.87 0.80
BI 0.89 0.80
NIHSS 0.77 0.73
EQ-5D 0.88 0.82
EQ-5D VAS 0.73 0.72
Rehabilitation study data
SIS 1.00
SF-SIS 0.96 1.00
SIS-VAS 0.56 0.57
BI 0.72 0.65
EQ-5D 0.69 0.69
EQ-5D VAS 0.46 0.40
BI indicates Barthel Index; EQ-5D, EuroQOl; mRS, modiﬁed Rankin Scale; NIHSS, National
Institutes of Health Stroke Scale; SIS, Stroke Impact Scale; SF-SIS, Short-Form SIS; VAS,
visual analog scale. All P<0.001.
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in a larger sample, has robust properties, and has been
reviewed by stakeholders.
The use of the VISTA data set allowed access to patient-
level data on thousands of trial participants. This size of data
set is considerably larger than that for most previous work
concerning derivation and validation of novel stroke out-
comes.10,24 As well as deriving the SF-SIS, VISTA data allowed
us to explore properties of the original SIS with an unprece-
dented precision. We note the high internal consistency of
SIS, suggesting that certain items in SIS may be noncontrib-
utory and supporting our work to create a condensed scale.
We note also that the emotional domain of SIS is problematic,
a feature worthy of further exploration. Previous work on
modifying existing assessment tools have tended to restrict
analyses to a single data set.25 We created independent data
sets for derivation and validation.
There are potential limitations of using VISTA. The data
were all from clinical studies and patients were younger and
had less severe stroke than unselected populations. While
this potentially limits external validity, we are reassured that
our SF-SIS broadly agreed with previous work on SIS using a
more representative cohort.10 There was differential avail-
ability of clinical and outcome data across the studies
included in VISTA. Based on initial scoping, we formulated an
analysis plan that made best use of the data; we did not
pool acute and rehabilitation data sets as available data
differed and intuitively these populations may give differing
scores on SIS. The rehabilitation data set had fewer
participants than the acute data set. The smaller data set
may limit power and external validity, although our sample
size is still much larger than that of most psychometric
studies of stroke scales.10,24
Table 5. Associations of SF-SIS With Clinical and Demographic Outcome Predictors—Acute Trial Data Set
Variable
Coefﬁcient (95% CI)
SIS-16 SF-SIS SF-SIS (Pilot)
Age 0.777 (0.851 to 0.702) 0.454 (0.523 to 0.386) 0.456 (0.521 to 0.392)
Baseline NIHSS 2.619 (2.79 to 2.45) 1.924 (2.082 to 1.766) 1.655 (1.807 to 1.504)
SBP 0.105 (0.14 to 0.069) 0.056 (0.090 to 0.023) 0.052 (0.083 to 0.021)
Glucose 1.223 (1.56 to 0.88) 0.619 (0.930 to 0.308) 0.596 (0.890 to 0.301)
Sex (female=1) 8.85 (10.78 to 6.92) 5.398 (7.149 to 3.647) 5.346 (6.992 to 3.698)
Use of tPA (yes=1) 4.287 (2.26 to 6.32) 2.163 (0.333 to 3.993) 2.140 (0.418 to 3.862)
AF (yes=1) 11.17 (13.5 to 8.84) 6.814 (8.922 to 4.706) 6.663 (8.647 to 4.678)
Prior stroke (yes=1) 4.16 (6.65 to 1.67) 4.427 (6.628 to 2.225) 4.952 (7.022 to 2.883)
AF indicates atrial ﬁbrillation; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; SF-SIS (pilot), short form of Stroke Impact Scale derived in initial pilot work;
SF-SIS, short form of Stroke Impact Scale derived from VISTA resource; tPA, tissue plasminogen activator (thrombolysis).
Table 6. Associations of SF-SIS With Clinical and Demographic Outcome Predictors—Rehabilitation Study Data Set
Variable
Coefﬁcient (95% CI)
SIS Full SF-SIS SF-SIS (Pilot)
Age 0.313 (0.449 to 0.178) 0.315 (0.469 to 0.161) 0.367 (0.527 to 0.206)
Sex 0.732 (2.541 to 4.005) 0.3646 (3.325 to 4.054) 1.094 (2.769 to 4.958)
Baseline BI 1.583 (1.303 to 1.863) 1.677 (1.352 to 2.003) 1.800 (1.462 to 2.137)
TIA 4.476 (8.31 to 0.637) 5.561 (9.851 to 1.271) 6.412 (10.927 to 1.897)
Previous Stroke 3.687 (7.847 to 0.472) 3.502 (8.199 to 1.195) 5.813 (10.696 to 0.930)
Heart failure 10.891 (20.17 to 1.61) 9.988 (20.44 to 0.47) 10.52 (21.55 to 0.51)
IHD 1.064 (4.731 to 2.604) 2.009 (6.125 to 2.108) 2.419 (6.755 to 1.917)
AF 4.028 (8.521 to 0.464) 4.985 (10.007 to 0.037) 3.669 (8.972 to 1.633)
AF indicates atrial ﬁbrillation; BI, Barthel Index; IHD, ischemic heart disease; SF-SIS (pilot), short form of Stroke Impact Scale derived in initial pilot work; SF-SIS, short form of Stroke
Impact Scale derived from VISTA resource; SIS full, complete Stroke Impact Scale; TIA, transient ischaemic attack.
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The use of a modiﬁed version of SIS (the SIS-16) in certain
acute studies limited the SIS data available and we had to
modify our analyses accordingly. Again, we are reassured that
this limitation has not systemically biased our results as there
was broad agreement with those data sets that had full SIS. The
focus group contained various clinical disciplines: stroke
survivors and their caregivers. For a more robust assessment
of acceptability, the tool should be assessed with more stroke
survivors and caregivers in the settings for which it is designed.
We would encourage further work of this nature. In moving to a
shorter version of an assessment scale, there is a tradeoff
between richness of data captured and the time and effort
required for completion. In our SF-SIS, certain items are not
explicitly measured. To ensure breadth of assessment, we have
kept 1 question from each functional domain. Loss of certain
itemswas an issue raised in our focus group, although the group
agreed on the ﬁnal set of items as an acceptable compromise.
We believe our SF-SIS has robust properties is acceptable to
patients and provides an alternative to original SIS. The ﬁnal
step of validation of any assessment scale concerns imple-
mentation. If the scale is adopted, we hope to collect
prospective data on feasibility, acceptability, and test proper-
ties. We would welcome feedback from those using the scale.
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SUPPLEMENTARY MATERIAL 
 
 
Data S1: Comments generated in focus group 
 
The materials below are comments from those who participated in our focus group discussing the 
strengths and limitations of various patient reported outcome measures used in stroke. The 
comments have been grouped under common themes, some comments are placed in more than 
one theme. The person who made the comment is described in parenthesis. 
 
Stroke impact scale too long / difficult to complete 
 
Some aspects not relevant to stroke (nurse) 
 
Size is very off-putting, but useful content (nurse and research nurse 1) 
This is too long (research nurse 2) 
Too much emphasis on physical aspects of stroke (clinical psychologist) 
There is a lot of repetition (stroke survivor 1) 
Far too many words (stroke survivor 1) 
 
In first weeks after stroke, I wouldn’t be able to understand this (stroke survivor 2) 
Content in this is good but looks like hard work (stroke survivor 3) 
Some editing required, uses too many or confusing words and terms (stroke survivor 3) 
 
Would need to think of the best time to use this, may not work in first days after stroke (stroke 
survivor 3) 
 
Would need to include a carer to complete this (OT) 
 
Difficult to get balance between content and length (physiotherapist) 
 
For research a more extensive questionnaire is needed, for clinical practice a shorter version is 
better (stroke physician) 
 
 
Wording of certain items could be improved 
 
Too many Americanisms (nurse) 
 
Wording is not the language most people would use (stroke survivor) 
Language seems negative eg “how difficult” rather than “how easy” 
There is a lot of repetition (stroke survivor 1) 
Far too many words (stroke survivor 1) 
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In first weeks after stroke, I wouldn’t be able to understand this (stroke survivor 2) 
Some editing required, uses too many or confusing words and terms (stroke survivor 3) 
This would be hard for someone with cognitive problems (OT) 
I don’t think any of the sentences are quite right (stroke survivor 3) 
 
 
 
Stroke impact scale is a detailed assessment 
 
This may be best as others not detailed enough, can we add some questions from this to other 
questionnaires (research nurse3) 
 
In first weeks after stroke, I wouldn’t be able to understand this (stroke survivor 2) 
Content in this is good but looks like hard work (stroke survivor 3) 
 
 
Some aspects of recovery not captured by Stroke Impact Scale 
 
Doesn’t capture role of the carer (stroke carer) 
 
Too much emphasis on physical aspects of stroke (clinical psychologist) 
Should there be a question on sleep/fatigue (stroke survivor 3) 
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Comments on short form SIS 
 
 
 
Short form Stroke Impact Scale may have benefits over the traditional scale 
 
Other questions seem about right (clinical psychologist) 
 
Like the questions except communication – only asks about understanding, doesn’t mention 
speaking (nurse) 
 
This is best of the three questionnaires but doesn’t cover enough (stroke survivor 2) 
The questions are easier to understand in this version (research nurse 1) 
Very long and very short versions may have a role in differing situations (stroke survivor 3) 
 
 
 
Short form Stroke Impact Scale may not capture some aspects of recovery 
 
Like the questions except communication – only asks about understanding, doesn’t mention 
speaking (nurse) 
 
Too “bare bones” one question to cover each area not enough (research nurse 3) 
 
Lose too much in the short version, I would end up elaborating on each question (research nurse 3) 
Doesn’t make sense to make it so short, is there a compromise (research nurse 3) 
This seems very focussed on physical recovery (stroke carer) 
 
This doesn’t address the emotional impact of stroke (stroke survivor 1) 
 
This is best of the three questionnaires but doesn’t cover enough (stroke survivor 2) 
This seems very short, could we have 16 questions rather than 8? (stroke survivor 3) 
Very long and very short versions may have a role in differing situations (stroke survivor 3) 
 
 
 
Wording of certain questions could be improved 
 
Can you think quickly question – seems abstract, is this relevant? (clinical psychologist) 
Question “walking” add something about balance. (stroke survivor 1) 
None of the scales are really suitable (stroke survivor 3) 
 
Question “how difficult was it to understand..” , what about responding? (stroke survivor 3) 
Question “think quickly”, this is difficult to answer. (stroke survivor 3) 
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Question “walk fast”, slow and steady is better than fast and falling (stroke survivor 3) 
Don’t like the walking question (stroke survivor 3) 
 at Glasgow University Library on July 7, 2016http://jaha.ahajournals.org/Downloaded from 
 Steering group members of the Virtual International Stroke Trials Archive 
(VISTA)  
 
VISTA-Acute 
 
K.R. Lees (Chair), A. Alexandrov, P.M. Bath, E. Bluhmki, N. Bornstein, L. Claesson, S.M Davis, G. 
Donnan, H. C. Diener, M. Fisher, M. Ginsberg, B. Gregson, J. Grotta, W. Hacke, M.G. Hennerici, M. 
Hommel, M. Kaste, P. Lyden, J. Marler, K. Muir, R. Sacco, A. Shuaib, P. Teal, N.G. Wahlgren, S. 
Warach, and C. Weimar. 
 
VISTA-Rehab 
 
M. Brady (Chair), M. Ali, A. Ashburn, D. Barer, J. Bernhardt, A. Bowen, E. Brodie, S. Corr, A. 
Drummond, J. Edmans, C. English, J. Gladman, E. Godecke, T. Hoffmann, L. Kalra, S. Kuys, P. 
Langhorne, A. C. Laska, K.R. Lees, N. Lincoln, P. Logan, L. Jongbloed, G. Mead, A. Pollock, V. Pomeroy, 
H. Rodgers, C. Sackley, L. Shaw, D.J. Stott, K.S. Sunnerhagen, S. Tyson, P. van Vliet, M. Walker, W. 
Whiteley. 
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